Overview
Lobbying Costs
37,500€
Financial year: Jan 2018 - Dec 2018
Lobbyists (Full time equivalent)
2.75 Fte (5)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Hellenic Association of Pharmaceutical Companies (SFEE)
EU Transparency Register
684432824847-17 First registered on 01 Dec 2016
Goals / Remit
The Hellenic Association of Pharmaceutical Companies (SFEE) represents one of the most innovative, productive and extrovert sectors of the national economy. It encompasses more than 95% of the pharmaceutical industry operating in Greece. Its 65 member companies – 27 Greek and 38 multinationals – are constantly investing in the development of effective medicines and treatments with a view to safeguarding the right of all citizens to health and better quality of life.
SFEE was established in 1982 and for more than 30 years now has championed the common interests of patients, pharmaceutical companies and their workforce. Since 1983, SFEE has been a member of EFPIA (European Federation of Pharmaceutical Industries and Associations), which is the voice of the pharmaceutical industry at the European Union level. EFPIA represents 34 associations of pharmaceutical companies in the EU Member States and 1,900 companies committed to researching, developing and bringing to patients new medicines that improve health and quality of life around the world.
With a high sense of responsibility towards Greek society, we act in the service of the common interests of the citizens, the State and the pharmaceutical companies. Our vision and mission are reflected in the formulation and support of principled and well-founded views that can crucially contribute to promoting public health and patients’ access to innovative and generic medicines. Compliance with the new, strict ethical rules is a fundamental requirement for all our member companies.
Pharmaceutical companies worldwide, and of course in Greece, play a pivotal role and make an undeniable contribution in the effort to achieve a high level of public health and thereby create conditions for economic growth and social progress.
The world pharmaceutical industry is one of the most dynamic, but also most sensitive, sectors of the global economy. The new medicines and revolutionary treatments are developed in the laboratories of pharmaceutical companies across the globe. We work systematically to maintain and strengthen the momentum of the ongoing pharmaceutical revolution and enhance mankind’s arsenal in the fight against diseases.Main EU files targeted
- EC proposal on HTA
- IP/SPC manufacturing waiver
- European Presidencies
- Patients Access to healthcare
- Cross-country collaborations
- BREXIT
- European SemesterAddress
Head Office
289 Kifissias av. and
3 Agriniou str
Halandri 15232
GREECE -
People
Total lobbyists declared
5
Employment time Lobbyists 75% 2 50% 2 25% 1 Lobbyists (Full time equivalent)
2.75
Lobbyists with EP accreditation
All Lobbyists with EP accreditation over time
0 accreditations were / are live (in bold) for the selected state of 04 Dec 2019
Name Start date End Date POLYXENI PAPADONIKOLAKI 23 Sep 2024 23 Sep 2025 Complementary Information
None declared
Person in charge of EU relations
Ms Jenny Papadonikolaki (Public Affairs Manager)
Person with legal responsibility
Mr Papadimitriou Olympios (President)
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Trade and business associations
-
Networking
Affiliation
SFEE is member of the European Federation of Pharmaceutical Inustries and Associations (EFPIA)
http://efpia.eu/
SFEE is member of the Hellenic Federation of Enerprises (SEV)
http://www.sev.org.grMember organisations
None declared
-
Financial Data
Closed financial year
Jan 2018 - Dec 2018
Lobbying costs for closed financial year
37,500€
Other financial info
n/a
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
SFEE is having official meetings with European Parliament Members regarding the National Agenda on healthcare and pharmacueticals.
Communication activities
None
Other activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 08 Apr 2022 Location Delphi Subject Pharma strategy in EU and Greece Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
-
Date 01 Oct 2020 Location Virtual event Subject EU Health Policies Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Margaritis Schinas (Vice-President)
- Maria Luisa Llano Cardenal (Cabinet member)
-
Date 29 Nov 2016 Location Berlaymont Subject exchange of vies on Pharmaceutical products distribution in refugee camps in Greece Cabinet Cabinet of Commissioner Christos Stylianides Portfolio Humanitarian Aid & Crisis Management Attending - Christos Stylianides (Commissioner)